Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 292654, 12 pages
http://dx.doi.org/10.1155/2015/292654
Clinical Study

Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney Transplantation

1Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria
2Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria
3Dialysis Institute Klagenfurt, Heiligengeistplatz 4/III, 9020 Klagenfurt, Austria

Received 4 July 2014; Accepted 9 February 2015

Academic Editor: Macaulay Onuigbo

Copyright © 2015 Ursula Thiem et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Messa, C. Cafforio, and C. Alfieri, “Clinical impact of hypercalcemia in kidney transplant,” International Journal of Nephrology, vol. 2011, Article ID 906832, 9 pages, 2011. View at Publisher · View at Google Scholar
  2. J. G. Heaf, E. Tvedegaard, I.-L. Kanstrup, and N. Fogh-Andersen, “Hyperparathyroidism and long-term bone loss after renal transplantation,” Clinical Transplantation, vol. 17, no. 3, pp. 268–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Perrin, S. Caillard, R. M. Javier et al., “Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation,” American Journal of Transplantation, vol. 13, no. 10, pp. 2653–2663, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Mazzaferro, M. Pasquali, F. Taggi et al., “Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 3, pp. 685–690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Gwinner, S. Suppa, M. Mengel et al., “Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications,” American Journal of Transplantation, vol. 5, no. 8, pp. 1934–1941, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. J. Kim, M. G. Kim, H. J. Jeon et al., “Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation,” Transplantation Proceedings, vol. 44, no. 3, pp. 651–656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Weisinger, R. G. Carlini, E. Rojas, and E. Bellorin-Font, “Bone disease after renal transplantation,” Clinical Journal of the American Society of Nephrology: CJASN, vol. 1, no. 6, pp. 1300–1313, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, “KDIGO clinical practice guideline for the care of kidney transplant recipients,” The American Journal of Transplantation, vol. 9, supplement 3, pp. S1–S155, 2009. View at Publisher · View at Google Scholar
  9. L. A. Hebert, J. Lemann Jr., J. R. Petersen, and E. J. Lennon, “Studies of the mechanism by which phosphate infusion lowers serum calcium concentration,” The Journal of Clinical Investigation, vol. 45, no. 12, pp. 1886–1894, 1966. View at Publisher · View at Google Scholar · View at Scopus
  10. R. W. Carey, G. W. Schmitt, H. H. Kopald, and P. A. Kantrowitz, “Massive extraskeletal calcification during phosphate treatment of hypercalcemia.,” Archives of Internal Medicine, vol. 122, no. 2, pp. 150–155, 1968. View at Publisher · View at Google Scholar · View at Scopus
  11. R. I. Breuer and J. LeBauer, “Caution in the use of phosphates in the treatment of severe hypercalcemia,” Journal of Clinical Endocrinology and Metabolism, vol. 27, no. 5, pp. 695–698, 1967. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Block, K. J. Martin, A. L. M. de Francisco et al., “Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis,” The New England Journal of Medicine, vol. 350, no. 15, pp. 1516–1525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Lindberg, B. Culleton, G. Wong et al., “Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 800–807, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Palmer, I. Nistor, J. C. Craig et al., “Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials,” PLoS Medicine, vol. 10, no. 4, Article ID e1001436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. B. Cohen, C. E. Gordon, E. M. Balk, and J. M. Francis, “Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis,” Transplantation, vol. 94, no. 10, pp. 1041–1048, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. T. B. Drüeke, “Cell biology of parathyroid gland hyperplasia in chronic renal failure,” Journal of the American Society of Nephrology, vol. 11, no. 6, pp. 1141–1152, 2000. View at Google Scholar · View at Scopus
  17. R. P. Paschoalin, J.-V. Torregrosa, A. Sánchez-Escuredo, X. Barros, C. E. Durán, and J. M. Campistol, “Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up,” Transplantation Proceedings, vol. 44, no. 9, pp. 2588–2589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. P. Paschoalin, J. V. Torregrosa, X. Barros, C. E. Durán, and J. M. Campistol, “Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal,” Transplantation proceedings, vol. 44, no. 8, pp. 2376–2378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-V. Torregrosa, E. Morales, J. M. Díaz et al., “Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study,” Nephrology, vol. 19, no. 2, pp. 84–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Borchhardt, H. Heinzl, E. Mayerwöger, W. H. Hörl, M. Haas, and G. Sunder-Plassmann, “Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation,” Transplantation, vol. 86, no. 7, pp. 919–924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Schemper and T. L. Smith, “A note on quantifying follow-up in studies of failure time,” Controlled Clinical Trials, vol. 17, no. 4, pp. 343–346, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Sprague, V. Belozeroff, M. D. Danese, L. P. Martin, and K. Olgaard, “Abnormal bone and mineral metabolism in kidney transplant patients—a review,” American Journal of Nephrology, vol. 28, no. 2, pp. 246–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Evenepoel, K. Claes, D. Kuypers, B. Maes, B. Bammens, and Y. Vanrenterghem, “Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study,” Nephrology Dialysis Transplantation, vol. 19, no. 5, pp. 1281–1287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Stavroulopoulos, M. J. D. Cassidy, C. J. Porter, D. J. Hosking, and S. D. Roe, “Vitamin D status in renal transplant recipients,” The American Journal of Transplantation, vol. 7, no. 11, pp. 2546–2552, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Y. Yakupoglu, A. Corsenca, P. Wahl, R. P. Wüthrich, and P. M. Ambühl, “Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft,” Transplantation, vol. 84, no. 9, pp. 1151–1157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Muirhead, J. S. Zaltman, J. S. Gill et al., “Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice,” Clinical Transplantation, vol. 28, no. 2, pp. 161–165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Sirilak, K. Chatsrisak, A. Ingsathit et al., “Renal phosphate loss in long-term kidney transplantation,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 2, pp. 323–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Uhlig, J. S. Berns, B. Kestenbaum et al., “KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD),” The American Journal of Kidney Diseases, vol. 55, no. 5, pp. 773–799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Triponez, O. H. Clark, Y. Vanrenthergem, and P. Evenepoel, “Surgical treatment of persistent hyperparathyroidism after renal transplantation,” Annals of Surgery, vol. 248, no. 1, pp. 18–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. V. Torregrosa and X. Barros, “Management of hypercalcemia after renal transplantation,” Nefrologia, vol. 33, no. 6, pp. 751–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Evenepoel, K. Claes, D. R. Kuypers, F. Debruyne, and Y. Vanrenterghem, “Parathyroidectomy after successful kidney transplantation: a single centre study,” Nephrology Dialysis Transplantation, vol. 22, no. 6, pp. 1730–1737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Coco, D. Glicklich, M. C. Faugere et al., “Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2669–2676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. E. A. S. Cruz, J. R. Lugon, V. Jorgetti, S. A. Draibe, and A. B. Carvalho, “Histologic evolution of bone disease 6 months after successful kidney transplantation,” The American Journal of Kidney Diseases, vol. 44, no. 4, pp. 747–756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Borchhardt, I. Sulzbacher, T. Benesch, M. Födinger, G. Sunder-Plassmann, and M. Haas, “Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation,” American Journal of Transplantation, vol. 7, no. 11, pp. 2515–2521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Rojas, R. G. Carlini, P. Clesca et al., “The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling,” Kidney International, vol. 63, no. 5, pp. 1915–1923, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Nagano and E. F. Nemeth, “Functional proteins involved in regulation of intracellular Ca2+ for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics,” Journal of Pharmacological Sciences, vol. 97, no. 3, pp. 355–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Tomida, T. Hamano, N. Ichimaru et al., “Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation,” Bone, vol. 51, no. 4, pp. 729–736, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. L. Serra, C. Wuhrmann, and R. P. Wüthrich, “Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism,” The American Journal of Kidney Diseases, vol. 52, no. 6, pp. 1151–1157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Finch, M. Tokumoto, H. Nakamura et al., “Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease,” The American Journal of Physiology—Renal Physiology, vol. 298, no. 6, pp. F1315–F1322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Hryszko, S. Brzosko, A. Rydzewska-Rosolowska, E. Koc-Zorawska, and M. Mysliwiec, “Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism,” International Urology and Nephrology, vol. 44, no. 5, pp. 1479–1486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. G. M. Connolly, R. Cunningham, P. T. McNamee, I. S. Young, and A. P. Maxwell, “Elevated serum phosphate predicts mortality in renal transplant recipients,” Transplantation, vol. 87, no. 7, pp. 1040–1044, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. E. Kruse, U. Eisenberger, F. J. Frey, and M. G. Mohaupt, “Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism,” Nephrology Dialysis Transplantation, vol. 22, no. 8, pp. 2362–2365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Szwarc, A. Argilés, V. Garrigue et al., “Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism,” Transplantation, vol. 82, no. 5, pp. 675–680, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. L. Serra, S. C. Braun, A. Starke et al., “Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation,” American Journal of Transplantation, vol. 8, no. 4, pp. 803–810, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Riccardi and E. M. Brown, “Physiology and pathophysiology of the calcium-sensing receptor in the kidney,” The American Journal of Physiology—Renal Physiology, vol. 298, no. 3, pp. F485–F499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. L. Serra, R. Savoca, A. R. Huber et al., “Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients,” Nephrology Dialysis Transplantation, vol. 22, no. 2, pp. 577–583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Borstnar, B. Erzen, T. G. Stopar et al., “Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients,” Transplantation Proceedings, vol. 42, no. 10, pp. 4078–4082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Courbebaisse, C. Diet, M.-O. Timsit et al., “Effects of cinacalcet in renal transplant patients with hyperparathyroidism,” The American Journal of Nephrology, vol. 35, no. 4, pp. 341–348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Esposito, L. Rostaing, I. Gennero, M. Mehrenberger, D. Durand, and N. Kamar, “Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient,” Clinical Nephrology, vol. 68, no. 4, pp. 245–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. L. W. Peng, J. L. Logan, S. H. James, K. M. Scott, and Y.-H. H. Lien, “Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient,” The American Journal of Medicine, vol. 120, no. 9, pp. e7–e9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Seikrit, A. Mühlfeld, H.-J. Groene, and J. Floege, “Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic,” Nature Reviews Nephrology, vol. 7, no. 4, pp. 237–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Guerra, I. A. Saavedra, E. J. Fernández et al., “Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet,” Journal of Nephrology, vol. 24, no. 1, pp. 78–82, 2011. View at Google Scholar · View at Scopus
  53. C. Bergua, J.-V. Torregrosa, D. Fuster, A. Gutierrez-Dalmau, F. Oppenheimer, and J. M. Campistol, “Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism,” Transplantation, vol. 86, no. 3, pp. 413–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Leca, M. Laftavi, A. Gundroo et al., “Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet,” American Journal of Transplantation, vol. 6, no. 10, pp. 2391–2395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. T. R. Srinivas, J. D. Schold, K. L. Womer et al., “Improvement in hypercalcemia with cinacalcet after kidney transplantation,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 2, pp. 323–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. R. L. Yang, K. Freeman, C. E. Reinke et al., “Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies,” Transplantation, vol. 94, no. 1, pp. 70–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. J.-M. El-Amm, M. D. Doshi, A. Singh et al., “Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation,” Transplantation, vol. 83, no. 5, pp. 546–549, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. E. Kruse, U. Eisenberger, F. J. Frey, and M. G. Mohaupt, “The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism,” Nephrology Dialysis Transplantation, vol. 20, no. 7, pp. 1311–1314, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Henschkowski, H. A. Bischoff-Ferrari, R. P. Wüthrich, and A. L. Serra, “Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation,” Kidney and Blood Pressure Research, vol. 34, no. 2, pp. 97–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Schwarz, S. Merkel, H. Leitolf, and H. Haller, “The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism,” Transplantation, vol. 91, no. 5, pp. 560–565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Schwarz, G. Rustien, S. Merkel, J. Radermacher, and H. Haller, “Decreased renal transplant function after parathyroidectomy,” Nephrology Dialysis Transplantation, vol. 22, no. 2, pp. 584–591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. M. E. Cho, Z. Duan, C. E. Chamberlain, J. C. Reynolds, M. S. Ring, and R. B. Mannon, “Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism,” Transplantation Proceedings, vol. 42, no. 9, pp. 3554–3558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. H. H. Malluche, M.-C. Monier-Faugere, G. Wang et al., “An assessment of cinacalcet HCI effects on bone histology in dialysis patients with secondary hyperparathyroidism,” Clinical Nephrology, vol. 69, no. 4, pp. 269–278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Yajima, T. Akizawa, Y. Tsukamoto, S. Kurihara, and A. Ito, “Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism,” Therapeutic Apheresis and Dialysis, vol. 12, supplement 1, pp. S38–S43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. K. A. Borchhardt, D. Diarra, I. Sulzbacher, T. Benesch, M. Haas, and G. Sunder-Plassmann, “Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation,” American Journal of Nephrology, vol. 31, no. 6, pp. 482–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. L. E. Nikkel, S. Mohan, A. Zhang et al., “Reduced fracture risk with early corticosteroid withdrawal after kidney transplant,” American Journal of Transplantation, vol. 12, no. 3, pp. 649–659, 2012. View at Publisher · View at Google Scholar · View at Scopus